NRAS and melanoma: We also demonstrate that triple wild-type cutaneous melanomas that lack mutations in BRAF, NRAS or NF1 have a similar TMB to the overall median and, in the majority of cases, demonstrate putative drivers in the MAPK pathway, suggesting that disease biology in these cases is likely similar to those melanomas with known Ras drivers.